Headlines

UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end

Newsquawk Staff ·

UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end.

Related headlines